ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma

Shishir K. Maithel; Jessica M. Keilson; Hop S.Tran Cao; Manali Rupji; Amit Mahipal; Bruce S. Lin; Milind M. Javle; Sean P. Cleary; Mehmet Akce; Jeffrey M. Switchenko; Flavio G. Rocha

doi:10.1245/s10434-023-13874-w

ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma

Shishir K. Maithel, Jessica M. Keilson, Hop S.Tran Cao, Manali Rupji, Amit Mahipal, Bruce S. Lin, Milind M. Javle, Sean P. Cleary, Mehmet Akce, Jeffrey M. Switchenko, Flavio G. Rocha

Medical Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	6569-6570
Number of pages	2
Journal	Annals of surgical oncology
Volume	30
Issue number	11
DOIs	https://doi.org/10.1245/s10434-023-13874-w
State	Published - Oct 1 2023

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-023-13874-w

Cite this

Maithel, S. K., Keilson, J. M., Cao, H. S. T., Rupji, M., Mahipal, A., Lin, B. S., Javle, M. M., Cleary, S. P., Akce, M., Switchenko, J. M., & Rocha, F. G. (2023). ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma. Annals of surgical oncology, 30(11), 6569-6570. https://doi.org/10.1245/s10434-023-13874-w

ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma. / Maithel, Shishir K.; Keilson, Jessica M.; Cao, Hop S.Tran et al.
In: Annals of surgical oncology, Vol. 30, No. 11, 01.10.2023, p. 6569-6570.

Research output: Contribution to journal › Article › peer-review

Maithel, SK, Keilson, JM, Cao, HST, Rupji, M, Mahipal, A, Lin, BS, Javle, MM, Cleary, SP, Akce, M, Switchenko, JM & Rocha, FG 2023, 'ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma', Annals of surgical oncology, vol. 30, no. 11, pp. 6569-6570. https://doi.org/10.1245/s10434-023-13874-w

@article{ed692820da634da9a0315cafeda78d6b,

title = "ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma",

author = "Maithel, {Shishir K.} and Keilson, {Jessica M.} and Cao, {Hop S.Tran} and Manali Rupji and Amit Mahipal and Lin, {Bruce S.} and Javle, {Milind M.} and Cleary, {Sean P.} and Mehmet Akce and Switchenko, {Jeffrey M.} and Rocha, {Flavio G.}",

year = "2023",

month = oct,

day = "1",

doi = "10.1245/s10434-023-13874-w",

language = "English (US)",

volume = "30",

pages = "6569--6570",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "11",

}

TY - JOUR

T1 - ASO Visual Abstact

T2 - NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma

AU - Maithel, Shishir K.

AU - Keilson, Jessica M.

AU - Cao, Hop S.Tran

AU - Rupji, Manali

AU - Mahipal, Amit

AU - Lin, Bruce S.

AU - Javle, Milind M.

AU - Cleary, Sean P.

AU - Akce, Mehmet

AU - Switchenko, Jeffrey M.

AU - Rocha, Flavio G.

PY - 2023/10/1

Y1 - 2023/10/1

UR - http://www.scopus.com/inward/record.url?scp=85171807450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85171807450&partnerID=8YFLogxK

U2 - 10.1245/s10434-023-13874-w

DO - 10.1245/s10434-023-13874-w

M3 - Article

C2 - 37468674

AN - SCOPUS:85171807450

SN - 1068-9265

VL - 30

SP - 6569

EP - 6570

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 11

ER -

ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this